3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
3
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
5
Genitourinary
4
Thoracic
3
Other
2
Gynecologic
2
Gastrointestinal
2
Classical hematology
2
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Head & Neck
1
Endocrine
1
Conditions
Neuroendocrine Tumors
52
Thyroid Neoplasms
19
Thyroid Cancer, Papillary
16
Carcinoma, Neuroendocrine
16
Pheochromocytoma
11
Adrenocortical Carcinoma
11
Thyroid Carcinoma, Anaplastic
10
Gastro-enteropancreatic neuroendocrine tumor
10
Small Cell Lung Carcinoma
9
Paraganglioma
9
Multiple Endocrine Neoplasia Type 1
9
Pituitary Neoplasms
8
Lung Neoplasms
8
Adenoma, Islet Cell
8
Sarcoma
7
Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Carcinoma, Medullary
6
Adenocarcinoma, Follicular
6
Colorectal Neoplasms
5
Central Nervous System Neoplasms
5
Carcinoma, Renal Cell
5
Carcinoma, Merkel Cell
5
Carcinoid Tumor
5
Somatostatinoma
4
Pancreatic Neoplasms
4
Neuroblastoma
4
Neoplasm Metastasis
4
Cholangiocarcinoma
4
Carcinoma, Hepatocellular
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Cardiovascular Diseases
×
Endocrine
×
Clear all
NCT04530916
2025-11-17
WB2020
Colorado State University
Phase 1/2
Active not recruiting
58 enrolled